Literature DB >> 16605286

Quality-of-life valuations of advanced breast cancer by New Zealand women.

Stephanie Land.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16605286     DOI： 10.2165/00019053-200624040-00010

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Quality-of-life valuations of advanced breast cancer by New Zealand women.

Authors:  Richard J Milne; Kathy H Heaton-Brown; Paul Hansen; David Thomas; Vernon Harvey; Alison Cubitt
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 2.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

Review 3.  The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine.

Authors:  L B Russell; M R Gold; J E Siegel; N Daniels; M C Weinstein
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

Review 4.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

Authors:  J E Siegel; M C Weinstein; L B Russell; M R Gold
Journal:  JAMA       Date:  1996 Oct 23-30       Impact factor: 56.272

5.  Using health-related quality-of-life information: clinical encounters, clinical trials, and health policy.

Authors:  J Tsevat; J C Weeks; E Guadagnoli; A N Tosteson; C M Mangione; J S Pliskin; M C Weinstein; P D Cleary
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.